GR38032F.
D002945:Cisplatin / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D017294:Ondansetron; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D014839:Vomiting / Q000517:prevention & control*
D007093:Imidazoles; D012702:Serotonin Antagonists; D017294:Ondansetron; D002945:Cisplatin